摘要:
The invention provides new heterocyclic compounds having the general formula (I) wherein A, L, X, m, n, R 1 and R 2 are as described herein, compositions including the compounds, processes of manufacturing the compounds, methods of using the compounds and methods of determining the monoacylglycerol lipase (MAGL) inhibitory activity of the compounds.
摘要:
The invention relates to a compound of formula (I) wherein A 1 , A 2 and R 1 to R 6 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
摘要:
The present invention provides a compound of formula (I) having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.
摘要:
The invention is concerned with novel pyrrolidine derivatives of formula (I) wherein X, Y, R 1 , R 2 and R 3 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
摘要:
The invention is concerned with novel pyrrolidine-3,4-dicarboxamide derivatives of Formula (I) ; wherein R l to R 9 and X are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
摘要:
The invention relates to a compound of formula (I) wherein A, B, D and R 1 to R 6 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.